Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Case Report
  • Published:

Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab

Bone Marrow Transplantation volume 29, pages 871–872 (2002)Cite this article

Abstract

Here, we report a case of paediatric β-thalassaemia major patient who underwent unrelated T cell-non- depleted bone marrow transplantation and developed a complication of autoimmune haemolytic anaemia (AIHA) refractory to corticosteroid and intravenous immunoglobulin therapy. After this child received two doses (375 mg/m2/dose) of rituximab (anti-CD20 monoclonal antibody), his AIHA was resolved.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1

Similar content being viewed by others

References

  1. Drobyski WR, Potluri J, Sauer D, Gottschall JL . Autoimmune hemolytic anemia following T cell-depleted allogeneic bone marrow transplantation Bone Marrow Transplant 1996 17: 1093 1099

    CAS  Google Scholar 

  2. Quartier P, Brethon B, Phillippet P et al. Treatment of childhood autoimmune haemolytic anaemia with rituximab Lancet 2001 358: 1511 1513

    Article  CAS  Google Scholar 

  3. Ahrens N, Kingreen D, Seltsam A, Salama A . Treatment of refractory autoimmune haemolytic anaemia with anti-CD20 (rituximab) Br J Haematol 2001 114: 241 246

    Article  Google Scholar 

  4. McLaughlin P, Grillo-Lopez AJ, Link BK et al. Rituximab chimeric anti-CD20 monoclonal antibody therapy for relapsed indolent lymphoma: half of patients respond to a four dose treatment program J Clin Oncol 1998 16: 2825 2833

    Article  CAS  Google Scholar 

  5. Zecca M, De Stefano P, Nobili B, Locatelli F . Anti-CD20 monoclonal antibody for the treatment of severe, immune-mediated pure red cell aplasia and hemolytic anemia Blood 2001 97: 3995 3997

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Pediatrics, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    S Hongeng

  2. Department of Pathology, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    P Tardtong & S Worapongpaiboon

  3. Department of Internal Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok, Thailand

    A Ungkanont & S Jootar

Authors
  1. S Hongeng
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. P Tardtong
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S Worapongpaiboon
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A Ungkanont
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. S Jootar
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hongeng, S., Tardtong, P., Worapongpaiboon, S. et al. Successful treatment of refractory autoimmune haemolytic anaemia in a post-unrelated bone marrow transplant paediatric patient with rituximab. Bone Marrow Transplant 29, 871–872 (2002). https://doi.org/10.1038/sj.bmt.1703551

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.bmt.1703551

Keywords

This article is cited by

Search

Advanced search

Quick links